Decision to end PEPFAR for South Africa reshapes HIV aid
PEPFAR funding for South Africa is set to end permanently, according to US sources, with officials citing unmet policy conditions unrelated to health.
Sofia Reyes ·

PEPFAR funding for South Africa is expected to be permanently wound down, US sources told Semafor, marking a major shift in Washington’s HIV aid strategy.
Congressional aides said the South Africa portfolio would be closed out by early next year, as the Trump administration pursues wider reductions to foreign assistance and global health programs across Africa.
US officials cite unmet policy conditions
A Senate aide said State Department officials justified the planned termination by pointing to South Africa’s alleged lack of “demonstrable progress” on a set of US policy requests.
Those requests included calls for Pretoria to scale back its relationship with Iran, to end Black Economic Empowerment policies, and to address the “Kill the Boer” chant associated with anti-apartheid-era politics, the aide said.
“None of these asks have anything to do with health,” the Senate aide argued, characterizing the conditions as political rather than public-health related.
South Africa’s national health department did not immediately respond to a request for comment, according to the report.
What the move means for a major HIV epicenter
The decision would affect one of the world’s largest HIV responses. South Africa has about 8 million people living with HIV, the highest number for any country.
PEPFAR has been a central channel for US health spending on the continent since it was created under President George W. Bush. Since the program’s launch, South Africa has received more than $8 billion in support, according to the figures cited in the report.
While the reporting did not detail which specific services would be reduced or transferred, PEPFAR’s footprint in South Africa has historically been tied to HIV prevention, treatment, and related health-system support.
Health experts and implementers often describe large HIV programs as multi-year ecosystems that rely on predictable financing. Abrupt or accelerated closures can complicate staffing, procurement cycles, and continuity for patients who require consistent care.
Broader aid cuts reshape US engagement in Africa
The planned end to South Africa’s PEPFAR financing comes in the context of broader US pullbacks from aid and international health initiatives in Africa, as described in the Semafor report.
PEPFAR has long carried both humanitarian and diplomatic weight for the United States, serving as a signature initiative in global health. A permanent exit from funding in a high-burden country would be a notable departure from the program’s traditional emphasis on sustained partnership and measurable epidemic control.
The timeline described by congressional aides suggests the next several months could determine how, and whether, any activities are transitioned to alternative funding streams. It also places scrutiny on whether future US global health support will be more explicitly linked to geopolitical and domestic-policy benchmarks.
Next steps are likely to include clarifying the scope of the closeout, the conditions attached to any remaining support, and how South Africa’s health authorities and partner organizations plan to maintain service delivery if US funds are withdrawn on schedule.